Shineway Pharmaceutical Group Ltd.

Shineway Pharmaceutical Group Ltd. is a large scale enterprise specializing in research and development, manufacturing and sales of modern Chinese medicines.  It is ranked as one of the top 5 enterprises in the Chinese medicine industry and as the company with the largest market capitalization among Hong Kong Stock Exchange main board listed pharmaceutical producers.  The company is also the largest manufacturer of Chinese medicine injections, soft capsules and granules in China in term of sales and production volume and technological standards.  The “Shineway” brand name is a Chinese Famous Trademark and one of China Top 100 Most Valuable Brands. The company has received hundreds of awards and recognitions including the Forbes Magazine’s Asia’s Best 200 Companies under a Billion, the Top 10 Most Admirable Pharmaceutical Enterprise in China, and Hong Kong Outstanding Enterprise, etc.

Shineway primarily targets on three market segments with high growth potential - namely the middle and old aged, anti-viral, and children.  The company focuses in developing modern Chinese medicine products of three main product groups – namely the Chinese medicine injection, Chinese medicine soft capsule and Chinese medicine granule, with emphasis in prescription medicines.  Shineway is presently the largest manufacturer of Qing Kai Ling Injection, Shen Mai Injection, Shu Xie Ning Injection, and Wu Fu Xin Nao Qing Soft Capsule in China.  Other products such as Huoxiang Zhengqi Soft Capsule, Qing Kai Ling Soft Capsule and Xiao'er Qingfei Huatan Granule are very popular in the country.

Shineway has modern manufacturing facilities and possesses large scale production capability. By utilizing advanced production knowhow and computer control technologies, Shineway enables standardization of Chinese medicine production, modernization of Chinese medicine dose forms, standardization in quality assurance protocols and production process automation.  The company’s capacities on Chinese medicine extraction and production of Chinese medicine injections, soft capsules and granules are first ranked in China. 

Shineway is committed to conform on international quality standards.  The company is GMP and GSP accredited in China, and it is also the first modern Chinese medicine producer receiving all three accreditations in ISO 9001, ISO 14001, and OHSAS 18001.  In addition, China Shineway is GMP certified by the TGA of Australia and hence our production workshops are recognized by more than 20 countries including the United Kingdom, Germany and France etc., under the PIC/S scheme.

Looking forward to the future, Shineway will continue to focus on the development of modern Chinese medicines. With relentless innovation, stringent management and our emphasis in eco-friendliness, Shineway is committed to develop Chinese medicine products with superb efficacy and safety.  We are geared to become the largest and professional manufacturer of Chinese medicine.